Mirati Therapeutics, Inc. announced that Jamie A. Donadio would cease serving as the Senior Vice President and Chief Financial Officer, principal financial officer and principal accounting officer of Mirati Therapeutics, Inc. and Chris LeMasters would cease serving as the Company's Executive Vice President and Chief Business Officer, effective immediately.